Ren Aonan, Wei Wanxing, Liang Zhengcheng, Zhou Min, Liang Taoyuan, Zang Ning
College of Chemistry and Chemical Engineering, Guangxi University Nanning 530004 China
School of Basic Medicine, Guangxi Medical University Nanning 530021 China.
RSC Med Chem. 2022 Oct 28;14(1):113-121. doi: 10.1039/d2md00340f. eCollection 2023 Jan 25.
Based on the inhibitory effect of CA-4 analogues and indoles on tubulin polymerization, we designed and synthesized a series of -((1-methyl-1-indol-3-yl)methyl)-2-(1-pyrazol-1-yl or triazolyl)--(3,4,5-trimethoxyphenyl)acetamides. All the synthesized compounds were evaluated for their antiproliferative activities against HeLa, MCF-7 and HT-29 cancer cell lines, and some of the target compounds demonstrated effective activities towards the three tumour cell lines. Among them, compound 7d exhibited the most potent activities against HeLa (IC = 0.52 μM), MCF-7 (IC = 0.34 μM) and HT-29 (IC = 0.86 μM). Mechanistic studies revealed that compound 7d induced cell apoptosis in a dose-dependent manner, arrested the cells in the G2/M phase and inhibited polymerization of tubulin a consistent way with colchicine. Therefore, 7d is a potential agent for the further development of tubulin polymerization inhibitors.
基于CA-4类似物和吲哚对微管蛋白聚合的抑制作用,我们设计并合成了一系列-((1-甲基-1-吲哚-3-基)甲基)-2-(1-吡唑-1-基或三唑基)--(3,4,5-三甲氧基苯基)乙酰胺。对所有合成化合物针对HeLa、MCF-7和HT-29癌细胞系的抗增殖活性进行了评估,一些目标化合物对这三种肿瘤细胞系表现出有效的活性。其中,化合物7d对HeLa(IC = 0.52 μM)、MCF-7(IC = 0.34 μM)和HT-29(IC = 0.86 μM)表现出最强的活性。机制研究表明,化合物7d以剂量依赖的方式诱导细胞凋亡,使细胞停滞在G2/M期,并抑制微管蛋白的聚合,其作用方式与秋水仙碱一致。因此,7d是进一步开发微管蛋白聚合抑制剂的潜在药物。